Multivariable analyses were not performed, but in a subgroup analysis of nonendometrioid carcinomas treated with radiotherapy, progression‐free survival, and overall survival were improved in MMR deficient cases compared with MMR proficient cases. This evidence concerns the gene MRC1 and carcinoma.